Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal haemoglobinuria. N Engl J Med 333:1253–1258CrossRefPubMed
2.
de Latour RP, Mary JY, Salanoubat C, French Society of Hematology, French Association of Young Hematologists et al (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112(8):3099–3106CrossRefPubMed
3.
Mukhina GL, Buckley JT, Barber JP, Jones RJ, Brodsky RA (2001) Multilineage glycosylphosphatidylinositol anchor deficient hematopoiesis in untreated aplastic anemia. Br J Haematol 115:476–482CrossRefPubMed
4.
Masako I, Koichi F, Tatsuhiko A (1998) Paroxysmal nocturnal clone in patients with myelodysplastic syndrome. Br J Hematol 102(2):465–474CrossRef
5.
Parker C, Omine M, Richards S, Nishimura J-I, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G, International PNH Interest Group (2005) Diagnosis and management of paroxysmal nocturnal haemoglobinuria. Blood 106:3699–3709CrossRefPubMedCentralPubMed
6.
Moyo VM, Mukhina GL, Garrett ES, Brodsky RA (2004) Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 126(1):133–138CrossRefPubMed
7.
Nishimura JI, Kanakura Y, Ware RE et al (2004) Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 83:193–207CrossRef
8.
Brodsky RA (2006) New insights into paroxysmal nocturnal hemoglobinuria. Hematol Am Soc Hematol Educ Program 516:24–28CrossRef
9.
Richards SJ, Rawstron AC, Hillmen P (2000) Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 42:223–233CrossRefPubMed
10.
Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA (2011) Natural history of paroxysmal nocturnal haemoglobinuria clones in patients presenting as aplastic anaemia. Eur J Haematol 87:37–45CrossRefPubMedCentralPubMed
11.
Sigimori C, Chujho T, Feng X et al (2006) Minorpopulation of CD55-CD59 blood cells predicts response to immunosuppressive therapy and prognosis ia patients with aplastic anemia. Blood 107:1308–1314CrossRef
12.
13.
Ghosh K (1994) How immature is the abnormal stem cell in paroxysmal nocturnal hemoglobulinuria? Am J Hematol 47:245CrossRefPubMed
14.
Savage WJ, Barber Jp, Mukhina GL et al (2009) Glycosyl phosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH. Exp Hematol 37:42–51CrossRefPubMedCentralPubMed
15.
Sugimori C, Mochizuki K, Qi Z et al (2009) Origin and fate of blood cells deficient in glycosylphosphatidylinositol anchored protein with bone marrow failure. Br J Haematol 147:102–112CrossRefPubMed
16.
Madkaikar M, Gupta M, Jijina F, Ghosh K (2009) Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitations. Eur J Haematol 83:503–511CrossRefPubMed
Metadata
Title
Morphological Spectrum of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Author
Kanjaksha Ghosh
Publication date
01-06-2015
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2015
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-013-0272-1

Other articles of this Issue 2/2015

Indian Journal of Hematology and Blood Transfusion 2/2015 Go to the issue

Case Report

Primary Follicular Lymphoma of the Breast: A Rare Clinical Entity Diagnosed Using Tissue Flow Cytometry

Review Article

Violating the Theory of Single Gene-Single Disorder: Inhibitor Development in Hemophilia

Original Article

Clinical and Hematological Profile of Acute Megakaryoblastic Leukemia: A 2 Year Study

Original Article

Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?

Original Article

Lupus Anticoagulants and Anticardiolipin Antibodies in Indian Women with Spontaneous, Recurrent Fetal Loss

Correspondence

Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits